These results imply that Rh1 had an inhibitory effect on the migration and proliferation of VSMCs induced by Ang II, and that Rh1 is a promising therapeutic agent for the treatment of vascular diseases, including atherosclerosis and restenosis. Here, AGT is linked to atherosclerosis.